Evidence map›Paper›PMID 32444777›Full record

ArticleCommunications biology2020

Genetic switches designed for eukaryotic cells and controlled by serine integrases.

Mayna S Gomide, Thais T Sales, Luciana R C Barros, Cintia G Limia, Marco A de Oliveira, Lilian H Florentino, Leila M G Barros, Maria L Robledo, Gustavo P C José, Mariana S M Almeida and 8 more

Open access · goldAbstract read
In one paragraph

Article in Communications biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. Structural basis of directionality control in large serine integrases.bioRxiv : the preprint server for biology · 2025
    Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Biocircuits in plants and eukaryotic algae.Frontiers in plant science · 2022
    Review
  10. Evaluation ofMicroorganisms · 2021
    Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 5 institutions in 2 countries.

Mayna S GomideBrazilian Agriculture Research Corporation - Embrapa - Genetic Resources and Biotechnology - CENARGEN, Brasília, 70770917, DF, Brazil.ORCID http://orcid.org/0000-0002-5717-7347
Thais T SalesBrazilian Agriculture Research Corporation - Embrapa - Genetic Resources and Biotechnology - CENARGEN, Brasília, 70770917, DF, Brazil.
Luciana R C BarrosMolecular Carcinogenesis Program, Research Coordination, National Cancer Institute (INCA), Rio de Janeiro, 20231050, RJ, Brazil.ORCID http://orcid.org/0000-0002-8633-716X
Cintia G LimiaMolecular Carcinogenesis Program, Research Coordination, National Cancer Institute (INCA), Rio de Janeiro, 20231050, RJ, Brazil.ORCID http://orcid.org/0000-0002-1749-3804
Marco A de OliveiraBrazilian Agriculture Research Corporation - Embrapa - Genetic Resources and Biotechnology - CENARGEN, Brasília, 70770917, DF, Brazil.
Lilian H FlorentinoBrazilian Agriculture Research Corporation - Embrapa - Genetic Resources and Biotechnology - CENARGEN, Brasília, 70770917, DF, Brazil.
Leila M G BarrosBrazilian Agriculture Research Corporation - Embrapa - Genetic Resources and Biotechnology - CENARGEN, Brasília, 70770917, DF, Brazil.ORCID http://orcid.org/0000-0003-2008-6609
Maria L RobledoMolecular Carcinogenesis Program, Research Coordination, National Cancer Institute (INCA), Rio de Janeiro, 20231050, RJ, Brazil.
Gustavo P C JoséBrazilian Agriculture Research Corporation - Embrapa - Genetic Resources and Biotechnology - CENARGEN, Brasília, 70770917, DF, Brazil.
Mariana S M AlmeidaBrazilian Agriculture Research Corporation - Embrapa - Genetic Resources and Biotechnology - CENARGEN, Brasília, 70770917, DF, Brazil.
Rayane N LimaBrazilian Agriculture Research Corporation - Embrapa - Genetic Resources and Biotechnology - CENARGEN, Brasília, 70770917, DF, Brazil.
Stevens K RehenD'Or Institute for Research and Education (IDOR), Rio de Janeiro, 22281100, RJ, Brazil.ORCID http://orcid.org/0000-0003-4216-9501
Cristiano LacorteBrazilian Agriculture Research Corporation - Embrapa - Genetic Resources and Biotechnology - CENARGEN, Brasília, 70770917, DF, Brazil.
Eduardo O MeloBrazilian Agriculture Research Corporation - Embrapa - Genetic Resources and Biotechnology - CENARGEN, Brasília, 70770917, DF, Brazil.
André M MuradBrazilian Agriculture Research Corporation - Embrapa - Genetic Resources and Biotechnology - CENARGEN, Brasília, 70770917, DF, Brazil.
Martín H BonaminoMolecular Carcinogenesis Program, Research Coordination, National Cancer Institute (INCA), Rio de Janeiro, 20231050, RJ, Brazil. mbonamino@inca.gov.br.ORCID http://orcid.org/0000-0002-4416-5822
Cintia M CoelhoDepartment of Genetic and Morphology, Institute of Biological Science, University of Brasília, Brasília, 70910900, DF, Brazil. cintiacoelhom@unb.br.ORCID http://orcid.org/0000-0002-8564-3587
Elibio RechBrazilian Agriculture Research Corporation - Embrapa - Genetic Resources and Biotechnology - CENARGEN, Brasília, 70770917, DF, Brazil. elibio.rech@embrapa.br.ORCID http://orcid.org/0000-0001-8588-0673
Brazilian Agricultural Research Corporation · BRInstituto Nacional de Câncer - INCA · BRUniversidade de Brasília · BRUniversidade Federal de Juiz de Fora · BRUniversidade Federal do Rio de Janeiro · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recently, new serine integrases have been identified, increasing the possibility of scaling up genomic modulation tools. Here, we describe the use of unidirectional genetic switches to evaluate the functionality of six serine integrases in different eukaryotic systems: the HEK 293T cell lineage, bovine fibroblasts and plant protoplasts. Moreover, integrase activity was also tested in human cell types of therapeutic interest: peripheral blood mononuclear cells (PBMCs), neural stem cells (NSCs) and undifferentiated embryonic stem (ES) cells. The switches were composed of plasmids designed to flip two different genetic parts driven by serine integrases. Cell-based assays were evaluated by measurement of EGFP fluorescence and by molecular analysis of attL/attR sites formation after integrase functionality. Our results demonstrate that all the integrases were capable of inverting the targeted DNA sequences, exhibiting distinct performances based on the cell type or the switchable genetic sequence. These results should support the development of tunable genetic circuits to regulate eukaryotic gene expression.

Indexed as

Recombination, GeneticAnimalsArabidopsisCattleFibroblastsHumansIntegrasesLeukocytes, MononuclearPlasmidsPromoter Regions, GeneticProtoplastsSerineIntegrasesSerine

Identifiers

PMID32444777
PMCPMC7244727
OpenAlexW3027819622

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.